• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Page 2 > Resources

Scientific articles

Page 2 > Resources

Scientific articles

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2026

Results

No results found. Please try using different filter option(s).

Global Health Now
In the media
27 May 2026

The Long, Strange Journey of Mycetoma Research

Global Health Now
Scientific articles
14 May 2026

In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting

International Journal for Parasitology: Drugs and Drug Resistance
Statements
19 May 2026

DNDi interventions at the 79th World Health Assembly

Dr Sergio Sosa-Estani
Statements
15 May 2026

DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’

Scientific articles
13 May 2026

Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression

PLOS Pathogens
Statements
13 May 2026

DNDi’s briefing note for 79th World Health Assembly

Close up of legs with sandals on a dry soil
Press releases
12 May 2026

DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai

Thai Rath logo
In the media
29 Apr 2026

Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure

Thai Rath
Scientific articles
14 May 2026

Mycetoma as a major cause of limb amputation in Northeastern Ethiopia: A facility-based retrospective study

PLOS Neglected Tropical Diseases
Nature Africa logo
In the media
6 May 2026

Fourteen days to recovery from kala-azar

Nature Africa
Scientific articles
30 Apr 2026

Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination

npj Antimicrobials and Resistance
Thai Rath logo
In the media
29 Apr 2026

ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด

Thai Rath
Press releases
27 Apr 2026

Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients

Alma Preta logo
In the media
25 Apr 2026

‘Estamos na fase de eliminação’: RD Congo avança no combate à doença que matou milhões na África

Alma Preta
Times of India logo
In the media
24 Apr 2026

Dengue treatments in 2-3 years, but cases set to rise with climate change

Times of India
The New Indian Express logo
In the media
23 Apr 2026

India eyes dengue treatment rollout within five years as vaccine pipeline advances

The New Indian Express
loading
Loading...
Scientific articles
22 Jan 2026

Analysis of the consultations on the InfoChagas digital platform

PLOS Neglected Tropical Diseases
Scientific articles
14 Jan 2026

Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to-moderate COVID-19 patients in sub-Saharan Africa

BMC Medicine
Scientific articles
14 Jan 2026

(Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance

The Lancet Microbe
Scientific articles
12 Jan 2026

Dengue therapeutics consortium 2025: a global collaboration in action

BMJ Global Health
Scientific articles
10 Jan 2026

Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challenges

International Journal of Pharmaceutics X
Scientific articles
9 Jan 2026

Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis

International Journal of Antimicrobial Agents
Scientific articles
9 Jan 2026

Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection

PLOS Neglected Tropical Diseases
Scientific articles
9 Jan 2026

Global health is in crisis: to reach neglected patients, we need to reimagine medical research

BMJ Global Health
Scientific articles
17 Dec 2025

Kronopolitides A–F, a family of 36-membered polyol macrolides with antiparasitic activity against Chagas disease

Journal of Natural Products
Scientific articles
2 Dec 2025

The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities

Parasites & Vectors
Scientific articles
25 Nov 2025

Bidirectional interaction between liposomal amphotericin B pharmacokinetics and parasite dynamics in patients with post-kala-azar dermal leishmaniasis: Potential implications for optimal dosing

Clinical Pharmacology & Therapeutics
Scientific articles
20 Nov 2025

Leishmaniasis

Nature Reviews Disease Primers
Scientific articles
20 Nov 2025

Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants

British Journal of Clinical Pharmacology
Scientific articles
4 Nov 2025

Host-derived molecules as novel chagas disease biomarkers: hypercoagulability markers and extracellular vesicles

Methods in Molecular Biology
Scientific articles
30 Oct 2025

Target product profile and discovery and development path for novel cryptococcal disease treatments

Journal of Infection
Scientific articles
7 Oct 2025

Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)

The Lancet Infectious Diseases
1 2 … 43 ›

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Youtube X-twitter Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license